The Onslaught Of HMOs Continues
Recently, according to foreign media reports, three HMOs of Chr. Hansen includes lactose-N-tetraose (LNT), 3-Fucosyllactose (3-FL), and 3′-Sialyllactose (3′-SL) Approved by the European Union for safe use in high doses in infant formula and several other products categories. The approval comes after the European Food Safety Authority (EFSA) assessed Chr. Hansen’s HMOs in May last year.
See the figure below for the specific dosage:
| HMOs | Chr Hansen’s Approval | Previously |
| 3′-SL | Infant formula max level: 0.23 g/L in the final product ready for use Follow-on formula max level: 0.28 g/L in the final product ready for use | Infant formula max level: 0.2 g/L in the final product ready for use Follow-on formula max level: 0.15 g/L in the final product ready for use |
| LNT | Infant formula max level: 1.82 g/L in the final product ready for use Follow-on formula max level: 1.82 g/L in the final product ready for use | Infant formula max level: 0.8 g/L in the final product ready for use Follow-on formula max level: 0.6 g/L in the final product ready for use |
| 3-FL | Infant formula max level: 0.90 g/L in the final product ready for use Follow-on formula max level: 1.20 g/L in the final product ready for use | Infant formula max level: 0.85 g/L in the final product ready for use Follow-on formula max level: 0.85 g/L in the final product ready for use |
This approval will allow Chr. Hansen customers use higher concentrations of HMOs in infant formula, making the formula more competitive.
Hansen HMO Senior Vice President Jesper Sig Mathiasen said: This approval will pave the way for the introduction of 5 HMO Mix developed by Chr. Hansen into infant formula in the highest concentration and in a more natural way.
It is reported that Chr. Hansen’s 5 HMO Mix also includes 2′-FL (2’fucosyllactose) and 6′-SL (6′-sialyl lactose).
At present, Chr. Hansen’s expert team is constantly exploring more unique health benefits of HMO. Its research shows that LNT contributes to the benefits of breastfeeding for infants, promoting the balance of the intestinal microbiome by limiting the growth of unwanted microorganisms. However, 3-FL increases concentration during lactation and becomes the most abundant HMO in human breast milk.
Source From: foodnavigator
